Related Experiment Video
Updated: Jan 9, 2026

15:04
Modeling and Simulations of Olfactory Drug Delivery with Passive and Active Controls of Nasally Inhaled Pharmaceutical Aerosols
Published on: May 20, 2016
11.3K
Nasal Fluid Dynamics Visualization Using Particle Image Velocimetry in a 3D-Printed Nasal Replica Model
Summary
This study introduces a novel method for visualizing nasal airflow, enhancing drug delivery research. The new technique combines Particle Image Velocimetry (PIV) with 3D-printed nasal models for accurate, real-time flow measurements.
Area of Science:
- Biomedical Engineering
- Fluid Dynamics
- Pharmacology
Background:
- Nasal drug delivery effectiveness relies on understanding airflow patterns.
- Traditional methods like dye visualization and CFD simulations have limitations in detailed 3D measurements and experimental validation.
- Accurate airflow data is crucial for optimizing nasal drug delivery systems.
Purpose of the Study:
- To develop an innovative experimental platform for precise nasal airflow pattern visualization.
- To overcome the limitations of existing methods in measuring 3D nasal airflow dynamics.
- To provide reliable experimental data for advancing nasal drug delivery technologies.
Main Methods:
- Development of an experimental platform integrating Particle Image Velocimetry (PIV).
- Utilization of a 3D-printed silicon-based nasal replica model.
- Non-invasive, real-time measurement of airflow dynamics within the nasal cavity.
Main Results:
- Successful implementation of a novel platform for direct, high-quality nasal airflow measurements.
- Acquisition of detailed 3D-flow pattern data, surpassing traditional methods.
- Demonstration of the platform's capability for real-time airflow dynamics assessment.
Conclusions:
- The developed PIV-integrated 3D-printed nasal model offers a superior method for nasal airflow visualization.
- This approach provides accurate, experimentally verified data for nasal drug delivery research.
- The findings offer practical insights for improving future nasal drug delivery technologies.

